Lv31
338 积分 2025-04-27 加入
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
4小时前
待确认
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
27天前
已完结
The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases
27天前
已完结
Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells
1个月前
已完结
Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): Isolated rat intestinal mucosae and sacs
1个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
1个月前
已完结
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study
1个月前
已完结
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
1个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
1个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
1个月前
已完结
皖公网安备34019202002308
